NJHA’s Ryan: New attempt to kill ACA would cost N.J. $3.9B in funds
The last-ditch attempt to replace the Affordable Care Act, a proposal by U.S. Sens. Lindsey Graham and Bill Cassidy, would cost New Jersey $3.9 billion in federal health care funds by 2026, according to...
Biologics firm Catalent makes $950M deal for drug services firm
Catalent Inc. has bought Bloomington, Indiana-based Cook Pharmica LLC for $950 million.
The Somerset-based company will pay $750 million upon closing for the integrated provider of drug substance and drug product manufacturing and related services.
The...
Christie unveils $200M, 25-initiative plan to fight N.J.’s opioid crisis
Gov. Chris Christie unveiled his plan to fight the opioid crisis in New Jersey on Tuesday afternoon, discussing some of the 25 new initiatives he will implement at a cost of approximately $200 million.
Speaking...
Morris County dementia care facility sold, IMG says
A family-owned dementia care facility was sold Monday.
The Country Home, in Morris County, is the fourth deal in the senior care industry that IMG Business Advisors completed in the past year.
The buyer was referred...
South Jersey’s Kennedy and Philly’s Jefferson finalize health care merger
South Jersey-based Kennedy Health System and Philadelphia-based Jefferson Health finalized their merger last week, and the two organizations plan to unveil a new logo next month for Kennedy.
The merger is one Kennedy desired, and...
NuVision names regional VP to oversee two S. Jersey facilities
NuVision Management announced its new South Jersey regional vice president to oversee both Weisman Children’s Rehabilitation Hospital in Marlton and Voorhees Pediatric Facility.
In his new role, Mike Rosiak will oversee financial and operational elements...
ROI-NJ Exclusive: LeBenger details national expansion plans for Summit
Dr. Jeffrey LeBenger, CEO of both Summit Health Management and Summit Medical Group, is taking his brands national.
LeBenger announced expansion into Oregon and Arizona on Thursday.
And that’s just the first step.
LeBenger, in an exclusive interview...
Biopharma firm Amarin names first chief commercial officer
Amarin Corp. announced a new position that will help build the biopharmaceutical company’s revenue growth as its first FDA-approved product is available by prescription.
Mark W. Salyer is Amarin’s first chief commercial officer. He was...
Phibro Animal Health buys Argentine company
Teaneck-based Phibro Animal Health Corp. is expanding its business with the purchase of an Argentine developer, manufacturer and marketer of animal health and nutritional products.
The purchase of Biotay S.A. also will give Phibro new...
Integra selling some neurosurgery assets for $47.5M
Integra LifeSciences Holdings Corp. has signed an agreement to sell certain neurosurgery assets to Natus Medical for $47.5 million.
The product lines made about $50 million in revenue last year.
The deal is contingent on the...
